SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001723128-21-000039
Filing Date
2021-11-08
Accepted
2021-11-08 16:43:11
Documents
99
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q amrx-20210930.htm   iXBRL 10-Q 2623410
2 EX-31.1 amrx-2021093010xqexx311.htm EX-31.1 10244
3 EX-31.2 amrx-2021093010xqexx312.htm EX-31.2 10370
4 EX-31.3 amrx-2021093010xqexx313.htm EX-31.3 10432
5 EX-32.1 amrx-2021093010xqexx321.htm EX-32.1 5723
6 EX-32.2 amrx-2021093010xqexx322.htm EX-32.2 5669
7 EX-32.3 amrx-2021093010xqexx323.htm EX-32.3 5757
  Complete submission text file 0001723128-21-000039.txt   12379652

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT amrx-20210930.xsd EX-101.SCH 88598
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT amrx-20210930_cal.xml EX-101.CAL 107593
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT amrx-20210930_def.xml EX-101.DEF 478883
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT amrx-20210930_lab.xml EX-101.LAB 901433
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT amrx-20210930_pre.xml EX-101.PRE 642389
13 EXTRACTED XBRL INSTANCE DOCUMENT amrx-20210930_htm.xml XML 2518744
Mailing Address 400 CROSSING BOULEVARD 3RD FLOOR BRIDGEWATER NJ 08807
Business Address (908) 947-3120
Amneal Pharmaceuticals, Inc. (Filer) CIK: 0001723128 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38485 | Film No.: 211388599
SIC: 2834 Pharmaceutical Preparations